SPP100 Dose Finding Study in Japan

Status:
Completed

Trial end date:
2005-03-01

Target enrollment:

Participant gender:

This study will evaluate the efficacy of SPP100 in lowering blood pressure in patients with essential hypertension.

Phase 2

Novartis